Primary clear cell adenocarcinoma of the bladder with recurrence: a case report and literature review

Clear cell carcinoma of the bladder is a rare tumor of the bladder. There are few reports available on this rare disease, and no cases with recurrence were reported. Here we present a case of 68-year-old woman with primary clear cell carcinoma of the bladder, who underwent repeat TUR-BT and tumor recurrence. We also reviewed the previous treatments and prognoses in previous case reports and evaluate the proper treatment for this disease. Once the diagnosis is determined, the radical surgery should be recommended. The recurrence is not prevented based on post-TUR intravesical therapy

Differentiation-dependent association of phosphorylated extracellular signal-regulated kinase with the chromatin of osteoblast-related genes

The ERK/MAP kinase pathway is an important regulator of gene expression and differentiation in postmitotic cells. To understand how this pathway controls gene expression in bone, we examined the subnuclear localization of P-ERK in differentiating osteoblasts. Induction of differentiation was accompanied by increased ERK phosphorylation and expression of osteoblast-related genes, including osteocalcin ( Bglap2 ) and bone sialoprotein ( Ibsp ). Confocal immunofluorescence microscopy revealed that P-ERK colocalized with the RUNX2 transcription factor in the nuclei of differentiating cells. Interestingly, a portion of this nuclear P-ERK was directly bound to the proximal promoter regions of Bglap2 and Ibsp . Furthermore, the level of P-ERK binding to chromatin increased with differentiation, whereas RUNX2 binding remained relatively constant. The P-ERK-chromatin interaction was seen only in RUNX2-positive cells, required intact RUNX2-selective enhancer sequences, and was blocked with MAPK inhibition. These studies show for the first time that RUNX2 specifically targets P-ERK to the chromatin of osteoblast-related genes, where it may phosphorylate multiple substrates, including RUNX2, resulting in altered chromatin structure and gene expression. © 2010 American Society for Bone and Mineral ResearchPeer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/64899/1/90705_ftp.pd

TorchAudio 2.1: Advancing speech recognition, self-supervised learning, and audio processing components for PyTorch

TorchAudio is an open-source audio and speech processing library built for PyTorch. It aims to accelerate the research and development of audio and speech technologies by providing well-designed, easy-to-use, and performant PyTorch components. Its contributors routinely engage with users to understand their needs and fulfill them by developing impactful features. Here, we survey TorchAudio's development principles and contents and highlight key features we include in its latest version (2.1): self-supervised learning pre-trained pipelines and training recipes, high-performance CTC decoders, speech recognition models and training recipes, advanced media I/O capabilities, and tools for performing forced alignment, multi-channel speech enhancement, and reference-less speech assessment. For a selection of these features, through empirical studies, we demonstrate their efficacy and show that they achieve competitive or state-of-the-art performance